UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000041152
Receipt number R000046535
Scientific Title Effects of health education intervention on diabetes control and cardiovascular risk modification among patients with type 2 diabetes mellitus patients in muscat, Oman
Date of disclosure of the study information 2020/08/30
Last modified on 2021/01/17 22:42:24

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effects of health education intervention on diabetes control and cardiovascular risk modification among patients with type 2 diabetes mellitus patients in muscat, Oman

Acronym

Effects of health education intervention on diabetes control and cardiovascular risk modification among patients with type 2 diabetes mellitus patients in muscat, Oman

Scientific Title

Effects of health education intervention on diabetes control and cardiovascular risk modification among patients with type 2 diabetes mellitus patients in muscat, Oman

Scientific Title:Acronym

Effects of health education intervention on diabetes control and cardiovascular risk modification among patients with type 2 diabetes mellitus patients in muscat, Oman

Region

Asia(except Japan)


Condition

Condition

Clinical trials

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To determine the effectiveness of the health education intervention on diabetes control and cardiovascular risk among type 2 diabetes patients in Muscat, Oman.

Basic objectives2

Others

Basic objectives -Others

1. To determine the following characteristics of patients with type 2 diabetes at baseline:
Sociodemographic characteristics (age, education level, sex, marital status, income)
Clinical factors (presence of diseases, duration of illness, medication, etc)
Dietary intake (macronutrients and micronutrients), dietary pattern and Mediterranean Diet Score
Lifestyle characteristics (smoking, alcohol consumption, physical activity level, sleep quality)
Anthropometric measurements
Risk of cardiovascular (blood pressure, high density lipoprotein cholesterol, low density lipoprotein cholesterol, ratio of total cholesterol to high density lipoprotein cholesterol, and triglycerides level)
2. To compare the mean difference in:
Mediterranean diet score, dietary intake, physical activity, anthropometric measurements, risk of cardiovascular, within and between control and intervention groups at three months (post-intervention 1) and six months (post-intervention 2) after intervention.

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Primary outcomes:
Decrease the Risk of cardiovascular:
HbA1c
Blood lipid profile (TG, LDL HDL, Total cholesterol/ HDL ratio)
Blood pressure (Systolic and diastolic)
Anthropometric measurements (Body mass index)

Key secondary outcomes

Secondary outcomes:
psychosocial factors
dietary behaviors


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Active

Stratification

YES

Dynamic allocation

YES

Institution consideration

Institution is considered as adjustment factor in dynamic allocation.

Blocking

NO

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Educational,Counseling,Training

Type of intervention

Behavior,custom

Interventions/Control_1

67/67

Interventions/Control_2

67/67

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

75 years-old >=

Gender

Male and Female

Key inclusion criteria

Inclusion criteria for current study were Omani men and women aged 18 to 75 years old, diagnosed with Type 2 diabetes, and receiving diabetes care from the NDEC with stable HbA1c less than 10% for at least 6 months.

Key exclusion criteria

Men and women who were severely impaired in vision, hearing, or speech. Additionally, Pregnant or lactating women and individuals who are diagnosed with cardiac failure or/and severe renal disease, with physical or mental disability, neurological or cognitive impairment. Individuals who have known allergy to peanuts/ or any components of the Mediterranean diet were excluded also.
Control group will be invited to the clinic in different days / clinic slots to avoid any possibility of contamination between them and intervention subjects. In addition, subjects in the control group will be assured that they will receive the same information as the intervention subjects at the end of the study.
In order to avoid any risks, patients with any type of known allergies related to Mediterranean diet will be excluded from the study. Subjects will be advised on potential symptoms of allergies. Clear instruction will be provided that subjects presented with allergies symptoms will need to seek medical treatment immediately.

Target sample size

134


Research contact person

Name of lead principal investigator

1st name Najwa
Middle name Salim
Last name AlAufi

Organization

Universiti Putra Malaysia

Division name

Department of Nutrition and Dietetics

Zip code

43400

Address

Jalan University, serdang, selangor, malaysia

TEL

0096871729525

Email

najwa-asu@outlook.com


Public contact

Name of contact person

1st name Najwa
Middle name Salim
Last name AlAufi

Organization

Universiti Putra Malaysia

Division name

Department of Nutrition and Dietetics

Zip code

43400

Address

Jalan University, serdang, selangor, malaysia

TEL

0096871729525

Homepage URL


Email

najwa-asu@outlook.com


Sponsor or person

Institute

Universiti Putra Malaysia

Institute

Department

Personal name



Funding Source

Organization

Universiti Putra Malaysia

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Universiti Putra Malaysia

Address

Jalan University, serdang, selangor, malaysia

Tel

0096871729525

Email

najwa-asu@outlook.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2020 Year 08 Month 30 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

126

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2019 Year 04 Month 28 Day

Date of IRB

2019 Year 03 Month 10 Day

Anticipated trial start date

2019 Year 11 Month 20 Day

Last follow-up date

2021 Year 11 Month 30 Day

Date of closure to data entry

2021 Year 11 Month 30 Day

Date trial data considered complete

2022 Year 02 Month 28 Day

Date analysis concluded



Other

Other related information



Management information

Registered date

2020 Year 07 Month 19 Day

Last modified on

2021 Year 01 Month 17 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046535


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name